Search Details

Word: hoechst (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...about possible conflicts between unbiased scientific investigation and corporate profits. Harvard again became a focal point of attention in this area this spring when two weeks after one of its teaching hospitals, the Massachusetts General Hospital, announced it had received a $60-million grant from the German chemical firm Hoechst, the Medical School announced that it had received a $6-million grant of its own from DuPont. Both of the grants will fund research in the controversial field of recombinant...

Author: By Charles W. Slack, | Title: Corporate Ties: A Look Back at Monsanto | 7/24/1981 | See Source »

...grant of $23 million for research to be conducted under the guidance of two Medical School professors. The announcement surprised--and provoked--many scientists at Harvard and nationwide, and some of the same questions were raised which have since been brought up in relation to the DuPont and the Hoechst deals...

Author: By Charles W. Slack, | Title: Corporate Ties: A Look Back at Monsanto | 7/24/1981 | See Source »

Sanders, who first came to the Medical School in 1958 as a research fellow in cardiology, presided over a successful $114 million fund drive at MGH and negotiated the recent $60-million agreement with the Hoechst Corporation of Germany, the world's largest pharmaceutical company, for research on DNA at the hospital...

Author: NO WRITER ATTRIBUTED | Title: MGH Chief Charles Sanders Resigns to Join Private Firm | 7/10/1981 | See Source »

After appearing at the NIH gathering and a subsequent set of hearings before the Science and Technology Committee, Lamont-Havers expresses impatience with "many deliberate misconceptions" associated with the Hoechst agreement and adds that "of course everything will be published as if there was no industrial money involved--we are still scientists first." Referring specifically to the House hearings, he says that "like anyone else, Congressmen are interested in gaining publicity when an important event occurs. That was their main motivation." After grilling Lamont-Havers, one committee member, Rep. Albert Gore (D. Tenn.) emerged from the conference room to tell...

Author: By Paul M. Barrett, | Title: Biotechnology and the Faustian Dilemma | 7/3/1981 | See Source »

Meanwhile, though, Mass General has declined to comply with a request from Congress to reveal the details of its agreement with Hoechst, a position that will no doubt continue to create distrust and may result in a formal subpoena, staffers on the Science and Technology Committee say. Harvard does not anticipate formal investigation of the Du Pont grant, but the same Congressional sources indicate that they will scrutinize the information available before deciding whether the public deserves to know more. "Unless we hear some good reason, there seems to be no benefit in this type of interference," Lamont-Havers says...

Author: By Paul M. Barrett, | Title: Biotechnology and the Faustian Dilemma | 7/3/1981 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next